JENNIFER SHIPP: Open Payments
NPI 1316450497 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$267 in 16 payments from 8 companies in 2025. Trend: 2023 $292 · 2024 $280 · 2025 $267
Food & beverage: $267
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $86 |
| AstraZeneca Pharmaceuticals LP | 4 | $61 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| SANOFI PASTEUR INC. | 1 | $17 |
| Exact Sciences Corporation | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $9 |
Products named: CAPLYTA, TRELEGY ELLIPTA, BREZTRI, AIRSUPRA, Cologuard Collection Kit, ZEPBOUND, Auvelity.
Industry payments across TX — which companies pay providers there.
